XML 14 R2.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 29, 2025
Dec. 29, 2024
Current assets:    
Cash and cash equivalents $ 135,978 $ 272,869
Short-term investments 67,434 0
Accounts receivable, net 4,244 4,566
Notes receivable, net 1,110 4
Inventory 13,385 7,664
Prepaid expenses and other current assets 6,189 9,903
Total current assets 228,340 295,006
Property and equipment, net 177,880 167,947
Customer relationship intangibles and other intangibles, net 34,015 36,394
Operating lease, right-of-use assets 12,353 13,479
Goodwill 12,217 12,217
Other assets, non-current 4,307 2,126
Total assets 469,112 527,169
Current liabilities:    
Accounts payable 13,906 9,492
Accrued expenses 6,216 19,843
Accrued compensation 8,301 8,228
Short-term debt 10,407 9,452
Deferred revenue 8,074 3,650
Other liabilities 5,371 3,036
Total current liabilities 52,275 53,701
Long-term debt, net 169,441 169,820
Warrant liability 18,469 28,380
Operating lease liabilities, non-current 12,182 13,293
Deferred revenue, non-current 300 3,774
Deferred tax liability 9,778 8,784
Other liabilities, non-current 15 14
Total liabilities 262,460 277,766
Commitments and Contingencies (Note 9)
Stockholders’ equity:    
Common stock, $0.0001 par value; authorized shares of 1,000,000,000; issued and outstanding shares of $192,957,823 and $190,559,335 as of June 29, 2025 and December 29, 2024, respectively 19 19
Additional paid-in-capital 1,093,245 1,067,951
Accumulated other comprehensive loss (391) (143)
Accumulated deficit (889,124) (821,086)
Total Enovix stockholders’ equity 203,749 246,741
Non-controlling interest 2,903 2,662
Total equity 206,652 249,403
Total liabilities and equity $ 469,112 $ 527,169